跳至主要内容
临床试验/ISRCTN95151471
ISRCTN95151471已完成未知

Antidyskinetic properties of topiramate: a double-blind, placebo-controlled trial in patients with Parkinson's disease and levodopa-induced dyskinesias

Salford Royal NHS Foundation Trust (UK)0 个研究点目标入组 30 人开始时间: 2008年7月2日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Both males and females, no age limits
  • 2. Patients with Parkinson's disease as defined by UK Parkinson's Disease Society Brain Bank criteria
  • 3. Current use of levodopa, dose to be stable for one month prior to enrolment
  • 4. Stable levodopa-induced dyskinesias

排除标准

  • 1. Hypersensitivity to topiramate or its excipients
  • 2. Prior surgery for PD
  • 3. Hoehn and Yahr score of 5 when off
  • 4. Dementia
  • 5. History of nephrolithiasis, renal impairment, liver disease, glaucoma
  • 6. Pregnancy and breastfeeding
  • 7. Premenopausal females and males not using adequate contraception
  • 8. Use of other antiepileptic drugs, carbonic anhydrase inhibitors, metformin, digoxin or illicit drugs

研究者

发起方
Salford Royal NHS Foundation Trust (UK)

相似试验